文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高胆固醇血清水平可增强自然杀伤细胞的抗肿瘤功能,并减少小鼠肝脏肿瘤的生长。

High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.

机构信息

International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China; National Center for Liver Cancer, Shanghai, China.

International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China; Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

出版信息

Gastroenterology. 2020 May;158(6):1713-1727. doi: 10.1053/j.gastro.2020.01.028. Epub 2020 Jan 21.


DOI:10.1053/j.gastro.2020.01.028
PMID:31972238
Abstract

BACKGROUND AND AIMS: The relationship between serum cholesterol level and development of hepatocellular carcinoma (HCC) remains unclear. We investigated the effects of serum cholesterol level on development of liver tumors in mice. METHODS: We performed studies with C57BL/6J mice, mice with disruption of the low-density lipoprotein receptor gene (Ldlrmice), and mice with conditional deletion of nature killer (NK) cells (NK mice). Some C57BL/6J and NK mice were given injections of diethylinitrosamine to induce liver tumor formation. Mice were placed on a normal diet (ND) or high-cholesterol diet (HCD) to induce high serum levels of cholesterol. We also studied mice with homozygous disruption of ApoE (ApoE mice), which spontaneously develop high serum cholesterol. C57BL/6J and NK mice on the ND or HCD were implanted with Hep1-6 (mouse hepatoma) cells and growth of xenograft tumors and lung metastases were monitored. Blood samples were collected from mice and analyzed by biochemistry and flow cytometry; liver and tumor tissues were collected and analyzed by histology, immunohistochemistry, and RNA-sequencing analysis. NK cells were isolated from mice and analyzed for cholesterol content, lipid raft formation, immune signaling, and changes in functions. We obtained matched tumor tissues and blood samples from 30 patients with HCC and blood samples from 40 healthy volunteers; levels of cholesterol and cytotoxicity of NK cells were measured. RESULTS: C57BL/6J mice on HCD and ApoE mice with high serum levels of cholesterol developed fewer and smaller liver tumors and lung metastases after diethylinitrosamine injection or implantation of Hep1-6 cells than mice on ND. Liver tumors from HCD-fed mice and ApoE mice had increased numbers of NK cells compared to tumors from ND-fed mice. NK mice or mice with antibody-based depletion for NK cells showed similar tumor number and size in ND and HCD groups after diethylinitrosamine injection or implantation of Hep1-6 cells. NK cells isolated from C57BL/6J mice fed with HCD had increased expression of NK cell-activating receptors (natural cytotoxicity triggering receptor 1 and natural killer group 2, member D), markers of effector function (granzyme B and perforin), and cytokines and chemokines compared with NK cells from mice on ND; these NK cells also had enhanced cytotoxic activity against mouse hepatoma cells, accumulated cholesterol, increased lipid raft formation, and immune signaling activation. NK cells isolated from HCD-fed Ldlr mice did not have increased cholesterol content or cytotoxic activity against mouse hepatoma cells compared with ND-fed Ldlr mice. Serum levels of cholesterol correlated with number and activity of NK cells isolated from human HCCs. CONCLUSIONS: Mice with increased serum levels of cholesterol due to an HCD or genetic disruption of ApoE develop fewer and smaller tumors after injection of hepatoma cells or a chemical carcinogen. We found cholesterol to accumulate in NK cells and activate their effector functions against hepatoma cells. Strategies to increase cholesterol uptake by NK cells can be developed for treatment of HCC.

摘要

背景和目的:血清胆固醇水平与肝细胞癌(HCC)的发展之间的关系尚不清楚。我们研究了血清胆固醇水平对小鼠肝脏肿瘤发展的影响。

方法:我们对 C57BL/6J 小鼠、低密度脂蛋白受体基因(Ldlr)敲除小鼠和自然杀伤(NK)细胞条件性缺失小鼠(NK 小鼠)进行了研究。一些 C57BL/6J 和 NK 小鼠接受二乙基亚硝胺注射以诱导肝肿瘤形成。小鼠被置于正常饮食(ND)或高胆固醇饮食(HCD)中以诱导血清胆固醇水平升高。我们还研究了载脂蛋白 E 基因(ApoE)纯合缺失(ApoE 小鼠)的小鼠,这些小鼠会自发地出现高血清胆固醇水平。将 C57BL/6J 和 NK 小鼠置于 ND 或 HCD 上,并植入 Hep1-6(小鼠肝癌)细胞,监测异种移植肿瘤的生长和肺转移。从小鼠中采集血液样本进行生物化学和流式细胞术分析;采集肝脏和肿瘤组织进行组织学、免疫组织化学和 RNA 测序分析。从小鼠中分离 NK 细胞,分析其胆固醇含量、脂筏形成、免疫信号转导以及功能变化。我们从 30 名 HCC 患者中获得了匹配的肿瘤组织和血液样本,从 40 名健康志愿者中获得了血液样本;测量了胆固醇水平和 NK 细胞的细胞毒性。

结果:HCD 喂养的 C57BL/6J 小鼠和高血清胆固醇水平的 ApoE 小鼠在接受二乙基亚硝胺注射或植入 Hep1-6 细胞后,肝脏肿瘤和肺转移的数量和体积均少于 ND 喂养的小鼠。与 ND 喂养的小鼠相比,HCD 喂养的小鼠和 ApoE 小鼠的肝肿瘤中 NK 细胞数量增加。在接受二乙基亚硝胺注射或植入 Hep1-6 细胞后,NK 缺失或 NK 细胞抗体耗竭的 NK 小鼠或小鼠在 ND 和 HCD 组中显示出相似的肿瘤数量和大小。与 ND 喂养的小鼠相比,HCD 喂养的 C57BL/6J 小鼠来源的 NK 细胞表达更多的 NK 细胞激活受体(自然细胞毒性触发受体 1 和自然杀伤组 2,成员 D)、效应功能标志物(颗粒酶 B 和穿孔素)以及细胞因子和趋化因子;这些 NK 细胞对小鼠肝癌细胞的细胞毒性也增强,积累胆固醇,增加脂筏形成,并激活免疫信号转导。与 ND 喂养的 Ldlr 小鼠相比,HCD 喂养的 Ldlr 小鼠来源的 NK 细胞的胆固醇含量或对小鼠肝癌细胞的细胞毒性没有增加。从人 HCC 中分离出的 NK 细胞的血清胆固醇水平与数量和活性相关。

结论:由于 HCD 或载脂蛋白 E 基因的遗传缺失,血清胆固醇水平升高的小鼠在注射肝癌细胞或化学致癌物后,肿瘤数量和体积减少。我们发现胆固醇在 NK 细胞中积累并激活其对肝癌细胞的效应功能。增加 NK 细胞摄取胆固醇的策略可用于 HCC 的治疗。

相似文献

[1]
High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.

Gastroenterology. 2020-1-21

[2]
EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.

J Immunother Cancer. 2020-3

[3]
Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.

Cell Mol Gastroenterol Hepatol. 2018-9-11

[4]
Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.

Gastroenterology. 2019-1-31

[5]
The miR-561-5p/CXCL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CXCR1 Natural Killer Cells Infiltration.

Theranostics. 2019-7-9

[6]
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.

Gastroenterology. 2020-8

[7]
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4 T-Cell-Dependent Control of Senescence.

Gastroenterology. 2019-1-30

[8]
Anti-cancer activity and mechanistic features of a NK cell activating molecule.

Cancer Immunol Immunother. 2009-10

[9]
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.

Gastroenterology. 2019-7-22

[10]
Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.

Cancer Immunol Res. 2014-10-14

引用本文的文献

[1]
Lipid Metabolism Reprogramming in Cancer: Insights into Tumor Cells and Immune Cells Within the Tumor Microenvironment.

Biomedicines. 2025-8-4

[2]
Association Between Diabetes and Site-Specific Cancer Risk: A Population-Based Cohort Study on the Differential Role of Metabolic Profiles.

J Diabetes Res. 2025-8-11

[3]
Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC.

Mol Cancer. 2025-6-11

[4]
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.

Cell Mol Immunol. 2025-6-11

[5]
Cholesterol-induced colorectal cancer progression and its mitigation through gut microbiota remodeling and simvastatin treatment.

BMC Cancer. 2025-6-1

[6]
Cholesterol biosynthesis induced by radiotherapy inhibits cGAS-STING activation and contributes to colorectal cancer treatment resistance.

Exp Mol Med. 2025-5-12

[7]
Novel insights and an updated review of metabolic syndrome in immune-mediated organ transplant rejection.

Front Immunol. 2025-4-22

[8]
Diet-induced dyslipidemia enhances IFN-γ production in mycolic acid-specific T cells and affects mycobacterial control.

Mucosal Immunol. 2025-8

[9]
PCSK9 Manipulates Lipid Metabolism and the Immune Microenvironment in Cancer.

Onco Targets Ther. 2025-3-27

[10]
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.

Mol Cancer. 2025-3-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索